Company Overview
Snapshot
Founded in January 1962, Mego Afek AC operates with 51–200 employees.
Business overview
Mego Afek AC specializes in the development and manufacturing of advanced medical and aesthetic compression therapy systems. The company's core technology focuses on dynamic compression to produce products like the Lympha Press line for lymphedema treatment, systems for venous insufficiency and peripheral arterial disease, and solutions for deep vein thrombosis prevention. Mego Afek also provides aesthetic and therapeutic techniques for muscular recovery and rehabilitation, serving home care, clinics, and hospitals globally within the Health Tech & Life Sciences sector.
Strategic signal
In June 2021, Mego Afek AC became the first Israeli company to sell its products in Morocco, signaling a significant expansion into new international markets. This move demonstrates the company's strategic intent to broaden its global footprint and tap into emerging healthcare markets, indicating potential for increased revenue streams and market penetration for its compression therapy systems.
Log in to access full profile ›Company Intelligence Q&A
- When was Mego Afek AC founded?
- Mego Afek AC was founded in January 1962.
- What is Mego Afek AC's primary business?
- Mego Afek AC specializes in developing and manufacturing medical and aesthetic compression therapy systems for home care, clinics, and hospitals.
- What was a key market expansion for Mego Afek AC in June 2021?
- In June 2021, Mego Afek AC became the first Israeli company to sell its products in Morocco, marking a significant international market entry.
- What product lines has Mego Afek AC developed?
- Mego Afek AC has developed product lines including Lympha Press for lymphedema and venous insufficiency, systems for peripheral arterial disease, and solutions for preventing deep vein thrombosis, alongside aesthetic and therapeutic recovery systems.